TENS may ease fibromyalgia pain briefly; benefits for daily function remain uncertain
A review of reviews found some short-term pain relief, while evidence for functional improvement was less certain and often not clinically meaningful.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review suggests that TENS may offer short-term pain relief for adults with fibromyalgia. Confidence in that finding ranged from low to moderate. Improvements in function and psychosocial outcomes were less consistent and usually not clinically meaningful, so pain relief should not be read as evidence of broader recovery.
The abstract reports varied treatment protocols and populations without a pooled effect size or detailed comparison groups. It therefore cannot show how large a benefit a particular patient might expect.
A review of existing reviews
Researchers examined reviews of transcutaneous electrical nerve stimulation, abbreviated TENS, rather than reporting a new treatment trial. They assessed review quality and evidence certainty separately, then summarized findings narratively because the underlying research varied.
Quality and certainty differ
Most included reviews had high methodological quality, yet certainty about functional benefits remained very low to low. TENS was described as well tolerated across reviews, but that safety summary does not resolve uncertainty about meaningful functional improvement.
The original publication
Targeting symptoms of fibromyalgia through transcutaneous electrical nerve stimulation (TENS): a systematic review of current systematic reviews.
Sahebari M, Tahmasbi F, Rahimi-Mamaghani A
Pain Med · 2026
- PubMed ID
- 41071642
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.